{"adverse_reactions":["Sincerus Florida, LLC adverse reactions sf"],"components":["Active, inactive e"],"effective_time":"20200702","id":"a97aeb21-4efd-3d91-e053-2995a90a2298","instructions_for_use":["Directions for use s"],"openfda":{},"package_label_principal_display_panel":["NDC 72934-1212-2 011504 DAPSONE 8.5% / NIACINAMIDE 4% gel 30 gm 2"],"set_id":"a97aeb21-4efc-3d91-e053-2995a90a2298","spl_product_data_elements":["011504 DAPSONE 8.5% / NIACINAMIDE 4% 011504 DAPSONE 8.5% / NIACINAMIDE 4% DAPSONE DAPSONE NIACINAMIDE NIACINAMIDE"],"version":"1"}